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Nanosilver has been studied as a valuable material for it strong antibacterial eﬀects. In this study, we investigated the antibacterial
properties of nano silver Poly-L-Lactic acid (Ag/PLLA) composite fibrous membranes. Ag/PLLA fibrous membranes were prepared
with silver nanoparticles having weight ratio of silver nanoparticles to PLLA at 5% (w/w). In vitro antibacterial tests were
performed using Escherichia coli (E. coli) and Staphylococcus aureus (Staph.) to determine the antibacterial capability of the
Ag/PLLA fibrous membranes. As the results suggested, Ag/PLLA fibrous membranes showed strong antibacterial properties. Thus,
Ag/PLLA fibrous membrane can be used as an antibacterial scaﬀold for tissue engineering.
Copyright © 2009 Lin Li et al. This is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1. Introduction
Tissue engineering scaﬀolds which are supposed to be used
for medical applications have applied various polymers such
as degradable Poly-L-Lactide (PLLA) and Polyglycolic acid
(PGA), or natural biomaterials like chitin, silk, protein,
and collagen [1–13]. These biomaterials oﬀer a promising
new approach to help to restore and reconstruct defected
tissues. An optimal scaﬀold for medical applications requires
the following merits: suitable for cell adhesion and pro-
liferation; highly porous for transport of nutrients and
metabolic waste; biodegradable and bioresorbable. PLLA
is a biocompatible, biodegradable, and immunologically
inert synthetic polymer. Thus, PLLA was chosen in this
study for designing a composition of tissue engineering
scaﬀold.
In addition, the risk of infection requires tissue engi-
neering scaﬀolds to have antibacterial properties [14]. For
example, during the treatment of wound, infection is a
common risk that need to be prevented for good healing
of wound. Due to their strong antibacterial properties and
low toxicity, silver and its compounds have been studied for
many years not only for their low toxicity, but also for their
antibacterial activity [14–27]. Yeo et al. found that fibers
having silver showed excellent antibacterial property [28].
Electrospinning technique was employed to produce PLLA
fibers to provide a matrix with wide interface for combining
antibacterial materials.
Meanwhile, the nanotechnology has provided a most
promising field for the new attempts of biomedical materials
[14]. Such as silver nanoparticles provide larger interface to
the environment than that of microscale silver particles. Li
et al. (2005) reported that nanosilver had strong antibacterial
eﬃcacy with very small amount against bacteria [17]. So,
nanosized silver is a good material to reduce the quantity
without decreasing antibacterial activity of silver. Thus, in
this study, we used the silver nanoparticles to combine
with PLLA by using electrospinning technique to fabricate
biodegradable tissue engineering scaﬀolds with antibacterial
property. E. coli and Staphylococcues which often infect
wound skin and other tissues were applied for antibacterial
tests to investigate the antibacterial activity of Ag/PLLA
fibrous membranes [28].
2. Materials and Methods
2.1. Materials. Poly-L-Lactide (PLLA) with molecular
weight of 1 000 000 was purchased from Purac, Netherlands.
Silver nanoparticles (0–100 nm) with 99.9% purity and
35 nm average particle size (Figure 1) were purchased from
the Shenzhen Junye Nano Material Co. Ltd.
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Figure 1: SEM images of silver nanoparticle (20 kV). Silver
nanoparticles are grey and white color with the average particle size
of 35 nm.
2.2. Electrospinning of PLLA and Ag/PLLA Membranes.
Electrospinning method is according to our previous study
[29]. PLLA was dissolved at the weight ratio of 1% in an
organic solvent mixed with the composition of chloroform
and N,N-dimethlformamide (DMF) (10 : 1, w/w). Silver
nanoparticles were then added to the solution and stirred
evenly to prepare 5% Ag/PLLA solution for electrospinning.
PLLA and Ag/PLLA solutions were taken in a syringe with
blunt needle, and fed by syringe plunger at a feeding rate of
0.3 mL/min. A grounded metal rotating drum wrapped with
aluminum foil was located at a fixed distance of 10 cm away
from the nozzle of the needle for collecting fibers. A high
electric field was applied to the droplet which was coming
out from the nozzle. This leads to the droplet deformation of
continuous fibers. PLLA and Ag/PLLA fibrous membranes
were produced under high voltage of 13 kV.
2.3. Antibacterial Test. Antibacterial test method was
referred to AATCC147-2004 in this study. Escherichia coli
(E. coli, ATCC25922) and Staphylococcus aureus (Staph.,
ATCC25923) were used for this test as the common micro-
organisms involved in hospital-acquired infections [17]. The
test repeated three times for every specimen.
2.3.1. Procedure. The strains were cultured overnight in
10 mL nutrient broth to achieve the turbidity of 108 colony
forming units (CFU)/mL. Sterilized nutrient agar was dis-
pensed by pouring 15 ± 2 mL into each standard (15 ×
100 mm) flat bottom petri dish to obtain firmly solid agar
before inoculating. Using a 4 mm inoculating loop, loaded
one loopful of the 10 times diluted inoculums and transfer
to the surface of the sterile agar by making five streaks
coving the central area of a petri dish. Gently press the
specimen of Ag/PLLA membrane to contact intimately with
the agar surface. Then incubated at 37◦C for 24 hours. PLLA
membrane was used as a negative control. All specimens were
prepared with the diameter of 5 mm for antibacterial test.
2.3.2. Evaluation. Examine the incubated plates for interrup-
tion of growth along the streaks of inoculum beneath the





Figure 2: Antibacterial test results of Ag/PLLA using Staphylococ-
cus (a) and E. coli (b) were used. The bacteria inhibition clear zones
of both E. coli and Staph. can be observed around the Ag/PLLA
membranes (lower specimen) with the average width of 5 mm after
24 hours incubation.
The average width of a zone of inhibition along a streak
on either side of the test specimen was calculated using the
following equation:
W = (T −D)
2
, (1)
where W = width of clear zone of inhibition in mm; T =
total diameter of test specimen and clear zone in mm; D =
diameter of the test specimen in mm.
2.4. Scanning Electron Microscopy (SEM). PLLA and
Ag/PLLA fibrous membranes with bacteria were sputter
coated with gold, then observed by scanning electron
microscopy (LEICA, Stereoscan 440, 20 kV).
2.5. Statistical Analysis. Values were expressed as means ±
standard deviations. Statistical diﬀerences were determined
by one-way ANOVA. P values of less than .05 were considered
to be statistically significant.
3. Results
3.1. Antibacterial Activities of Ag/PLLA Fibrous Membranes.
E. coli and Staph. were used for this test to evaluate the
antibacterial capability of Ag/PLLA fibrous membranes. The
bacteria were cultured overnight in 10 mL nutrient broth to
achieve the turbidity of 108 colony forming units (CFU)/mL.
A loop of each kind of bacteria at the concentration of
108 CFU/mL was taken to evenly streak the agar filled petri
dishes. Each of the circular specimens with 5 mm diameter
was gently pressed on the inoculated agar surface before
incubation at 37◦C for 24 hours.
As shown in Figure 2, the upper specimens were PLLA
membranes, the lower specimens were Ag/PLLA mem-
branes. All the membranes were freshly prepared. After 24
hours incubation, obvious bacteria inhibition clear zones of





Figure 3: Antibacterial activity of Ag/PLLA fibrous membrane
(lower specimen) reduced after exposure in the air for 8 weeks. The
average width of E. coli and Staph. inhibition clear zones decreased
to 1.2 mm and 1.5 mm, respectively, after 24 hours incubation.
Ag/PLLA membranes could be seen, the average width of the
zones was 55.0 ± 0.1 mm. While no clear zone of inhibition
was seen around PLLA membranes. Both Staph. and E. coli
had the same results which indicated the strong antibacterial
activity of Ag/PLLA.
After exposure in the air for 8 weeks, Ag/PLLA mem-
branes were still observed antibacterial activity. The average
width of bacterial inhibition zones of Ag/PLLA membranes
was 1.2± 0.1 mm with E. coli, and 1.5± 0.1 mm with Staph.
According to Table 1, the antibacterial activity was found to
decrease significantly (see Figure 3).
These results showed that Ag/PLLA membranes had
strong antibacterial capability. Although the membranes
were exposure in the air for a long term, they were still
antibacterial.
3.2. SEM Observation of Staph. on PLLA and Ag/PLLA
Fibrous Membranes. The morphological changes of bacteria
were also observed through SEM using Staph. 20 μL diluted
inoculum of Staph. at the concentration of 107 CFU/mL were
spread on the PLLA and Ag/PLLA membranes, respectively,
before being incubated at 37◦C for 2 hours. SEM observa-
tions were then performed.
As shown in Figure 4, the number of Staph. spread
on PLLA membrane was obviously more than that on
Ag/PLLA membrane. Besides, the surface of Staph. on PLLA
membrane was smoother than that on Ag/PLLA membrane.
This result indicated that there might be less destroy on the
structure of bacteria which spread on PLLA membrane than
that on Ag/PLLA membrane.
4. Discussion
Tissue engineering scaﬀolds with the eﬀectiveness in reduc-
ing the possibility of infections will be more acceptable
for medical applications [13]. For example, skin is the first
protective barrier for all the tissues and organs, so a wound
on skin will easily weaken the anti-infective capability of
human body. Here we mainly focused on the feasibility to
fabricate an antibacterial scaﬀolds for wound healing.
PLLA
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Figure 4: SEM images magnified Staph. on PLLA and Ag/PLLA
fibrous membrane 20 thousand times (20 kV). (1) The number of
Staph. on PLLA membranes was more than that on the Ag/PLLA
membrane. (2) Staph. on PLLA membrane had smooth surface,
while the ones on Ag/PLLA membrane were not very smooth.
Nanosilver was observed to be toxic to bacteria cells.
This finding suggested an exploration of the antibacterial
tissue engineering scaﬀolds [12, 13, 24]. In 2004, Alt
et al. reported that bone cement with 1% of nanosilver
showed high antibacterial activity against most of the tested
bacteria [13]. Yeo et al. found that fibers having nanosilver
showed excellent antibacterial property. Besides, PLLA was
already approved by FDA as a safe material for the clinical
application. Thus, to combine silver nanoparticles and PLLA
by using electrospinning technique [1–4] could be a good
approach to produce tissue engineering scaﬀolds with high
antibacterial eﬀect. On the other hand, electrospun fibers can
produce ventilate fibrous membranes with wide interface to
highly perform their antibacterial activity.
In the antibacterial tests, PLLA membranes were set as
control specimen. The Ag/PLLA membranes were found
to inhibit the proliferation of E. coli and Staphylococcus
significantly. On the basis of this finding, silver nanoparticles
were approved to be released from PLLA fibers gradually. In
terms of the degradability of PLLA, Ag/PLLA is an optimal
matrix to contain silver nanoparticles and help to gradually
release silver nanoparticles as PLLA degrade. Accordingly,
Ag/PLLA fibrous membrane is a good candidate antibacterial
substance for tissue engineering.
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Table 1: Assessment of the antibacterial activity of the extractions of Ag/PLLA membranes.
Bacteria
Average width of bacteria inhibition clear zone (mm)
PLLA 5% Ag/PLLA
Before
Escherichia coli 0 5.0± 0.1∗
Staphylococcus aureus 0 5.0± 0.1∗
After
Escherichia coli 0 1.2± 0.1∗
Staphylococcus aureus 0 1.5± 0.1∗
∗
The mean values were shown for means ± SD. P < .05 versus PLLA membranes.
Meanwhile, although the Ag/PLLA membrane was
proved to be antibacterial in this study, the antibacterial
activity of the membrane was observed decreasing. After
eight-week exposure in the air, the antibacterial activity of
the Ag/PLLA fibrous membranes reduced. This result may
be caused by the oxidization by the air or other reactions
during the exposure. So, further investigation about the
factors which aﬀect the antibacterial properties of Ag/PLLA
membrane need to be performed in the next process. These
findings also suggest that it is possible to keep Ag/PLLA
membrane with strong antibacterial activity for long
time.
To investigate the mechanism of the antibacterial activity
of Ag/PLLA membranes, morphological change of bacteria
were primarily observed by SEM. More Staph. were seen on
PLLA membrane than that on Ag/PLLA membrane. And
the surface of Staph. on PLLA membranes was smoother
than that on Ag/PLLA membranes. These findings imply that
nanosilver may aﬀect the structure of bacterial membrane,
thereby cause the defunctionalization of bacteria. The mech-
anism of antibacterial activity of Ag/PLLA membranes needs
further study to be verified.
On the other hand, based on the review of silver
toxicity studies, it was reported that the possible side
eﬀects of nanoparticles had not been much investigated,
so, detailed study needs to be carried out before the
merchandised product is introduced to the market [30].
But, as a strong antibacterial substance, silver nanoparticles
have been playing an irreplaceable role in anti-infections.
Hence, the further study needs to be carried on for both
the antibacterial function and toxicity of silver nanoparticles
composed materials to find out the safe balance point for
antibacterial scaﬀolds with no toxicity to the human body
and environment.
5. Conclusions
This study describes the antibacterial capability of the
Ag/PLLA fibrous membrane. On the basis of the observa-
tions and findings above, it can be concluded that PLLA is a
good matrix for containing and gradually releasing antibac-
terial substance, while silver nanoparticles can provide strong
antibacterial property to the Ag/PLLA fibrous membranes.
Thus, Ag/PLLA fibrous membrane can be used as an antibac-
terial scaﬀold for wound healing. Besides, the factors which
influence the antibacterial eﬀect need further investigation
to clarify the mechanism of antibacterial activity of Ag/PLLA
membranes.
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